Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
|
Leading accounting academic receives Lifetime Award
economia The American Accounting Association (AAA) has recognised professor of accountancy and honorary member of the ICAEW, Stephen Zeff, for his contribution to the profession. Zeff, who is Keith Anderson professor of accounting at Rice Jones Graduate School … |
June 14, 2017 at 05:49PM
from
|
KEMET Announces Election of Yasuko Matsumoto to KEMET Board of Directors
Nasdaq Ms. Matsumoto currently serves on the board of directors of Nippon Avionics Co., Ltd. (listed on the Tokyo Stock Exchange), Netcracker Technology Corporation and NEC Energy Devices, Ltd. Ms. Matsumoto served as a director of NEC TOKIN Corporation … |
June 14, 2017 at 05:49PM
from
Sources: https://goo.gl/UpprQe T-Shirts: http://ift.tt/29fxWnf In This Episode: China is consistently being used as the success story for the financial world. It is often reported that China will have perpetual growth and that there can…
June 11, 2017 at 05:47PM
from IWB
http://ift.tt/eA8V8J
by DCG Reza is done at CNN. I did a blog post on Raslan’s inappropriate tweet regarding Trump’s appropriate response to the London attack. Read about it here. Time to find another job, libtard….
June 11, 2017 at 05:47PM
from IWB
http://ift.tt/eA8V8J
by BNI He didn’t know it was against the law because the mandate to beat one’s wife when she is disobedient comes straight out of the Qur’an: JihadWatch “Men have authority over women because Allah…
June 11, 2017 at 05:47PM
from IWB
June 11, 2017 at 05:48PM
from
http://ift.tt/eA8V8J
by WashingtonsBlog Painting by Anthony Freda Presidents, Prime Ministers, Congressmen, Generals, Spooks, Soldiers and Police ADMIT to False Flag Terror In the following instances, officials in the government which carried out the attack (or…
June 11, 2017 at 05:47PM
from IWB
June 11, 2017 at 05:48PM
from
Leading diversified Canadian communications and media company, Rogers Communications Inc.’s RCI subsidiary, Rogers Media, Inc., signed two major deals which are likely to boost its business and open up scope for newer opportunities in the entertainment and media industry.
Rogers Media inked a new deal with The Weather Company — The Weather Company is a subsidiary of the Data and Analytics Platform business unit of International Business Machines Corporation IBM — and an extended deal with Iowa-based media conglomerate company, Meredith Corporation MDP.
Rogers Media and The Weather Company will team up to provide in-depth weather data and forecasts and content customized specifically for the Canadian market. The Weather Company and Rogers Media Sales further plans to enhance advertising across both the companies’ properties, with the latter leverage its advertising sales capabilities to monetize the former’s properties in Canada. The output can be easily accessed by both national and local Canadian marketers.
Meredith, which includes Canada’s no.1 digital food site – allrecipes.com, will help expand and enhance Rogers Media Sales’ reach in the food and lifestyle vertical.
Currently, Rogers Communications is a Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Expected Synergies
Rogers Media is a diversified media platform which offers radio and television broadcasting, sports entertainment, publishing, televised and online shopping, magazines and digital media properties. These latest deals are expected to increase the scalability and business opportunities of Rogers Media’s advertising segment, through the availability of different brands. This well help the advertisers better understand the connections between the brands and their customers.
We believe through this deal, Rogers Media will be able to expand and deliver brand-safe, premium-content environments to its advertising partners which will focus on lifestyle, entertainment, news and information verticals. Every month, more than 13.8 million Canadians visit Rogers Media digital properties across all devices.
On the back of these new deals, Rogers Media digital network is expected to reach upto 24.7 million Canadians, building strategic partnerships based on world-class organizations including the National Hockey League, Major League Baseball, Conde Nast Entertainment, and many more.
Price Performance
Over the past three months, share price of Rogers Communications inched up 12.23%, outperforming the Zacks-categorized Cable Television industry’s 9.24% gain.
Amid such booming prospects and an impressive price performance, Rogers Communications continues to face tough competition from market incumbents like TELUS Corp. TU and BCE Inc. (BCE), and other small regional cable TV operators in the wireless market of Canada. Shaw Communications Inc.’s (SJR) entry into the Canadian Wireless market with the WIND Mobile acquisition has intensified competition.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we’re mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold…
By last year, it was already generating $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “the world’s first trillionaires,” but that should still leave plenty of money for those who make the right trades early. See Zacks’ Top 3 Stocks to Ride This Space >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Business Machines Corporation (IBM): Free Stock Analysis Report
TELUS Corporation (TU): Free Stock Analysis Report
Rogers Communication, Inc. (RCI): Free Stock Analysis Report
Meredith Corporation (MDP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
June 07, 2017 at 05:48PM
from Zacks Equity Research
Companies in the homebuilding space have been enjoying good tidings of late given the positive fundamentals of the housing market. The positive momentum is evident from the robust Zacks Industry Rank (Top 15% out of more than 250 industries). In fact, the Zacks Building Building Residential/Commercial industry has outperformed the broader market on a year-to-date basis, as you can see below:
The housing/homebuilding industry has been riding high on steady job and wage growth, affordable mortgage rates, rising rentals, rapidly increasing household formation and a limited supply of inventory. Meanwhile, the rise in mortgage rates seems to be having a minimal effect on the industry.
One such company cashing in on the positive momentum is M/I Homes, Inc. MHO — one of the nation’s leading builders of single-family homes. Let us delve deeper into the other factors which makes this Zacks Rank #1 (Strong Buy) stock a lucrative pick.
Stock Price Movement: M/I Homes’ shares have gained 41.4% in the last one year, compared to the Zacks categorized Building Residential/Commercial industry’s 16.4% rise. That said, we have noticed that M/I Homes has outperformed the industry in the 12-week and 52-week frame. The overall improvement in the U.S. economy along with the improving housing momentum is expected to drive results in 2017.
Earnings History & Growth: M/I Homes has put up a historical EPS growth rate (average trailing 12-month EPS growth rate over the last 3-5 years of actual earnings) of 44.6%, compared with the industry average of 18.9%. Moreover, the company’s earnings is looking to grow at a rate of 36.2% in 2017, while the Zacks categorized Building Residential/Commercial industry’s earnings are likely to grow 17.3%.
Valuation Looks Rational: M/I Homes has a Value Style Score of ‘B’, putting it into the top 40% of all stocks we cover from this perspective.
We find the price-to-book ratio as the best multiple for valuing homebuilders because of their asset-driven nature. M/I Homes currently has a trailing 12 month P/B ratio of 1.14, comparing favorably with the industry’s P/B ratio of 1.66. Hence, its lower-than-market positioning hints at more upside in the quarters ahead.
Also, the company has a trailing 12-months price-to-earnings (P/E) ratio of 11.65, while the industry’s average stands at 13.86. Moreover, its forward P/E ratio (price compared to this year’s earnings) is at 9.36. This indicates that a slightly more value-oriented path may be ahead for M/I Homes.
Estimate Revisions: Earnings estimates for the current quarter and year have also gone up by 17.5% and 17.3%, respectively, over the past 60 days. The upside in earnings estimate revisions shows unwavering confidence that analysts have in the company. You can see the consensus estimate trend and recent price action for the stock in the chart below:
KB Home Price and Consensus
Bottom Line
M/I Homes’ robust Zacks industry Rank and a solid Zacks Rank instill investor confidence. Add to this the positive estimate revisions and robust value metrics, and we believe that we have a solid investment option in M/I Homes.
Other Stocks to Consider
Other top-ranked stocks in the industry include Lyon William Homes WLH, Lennar Corporation LEN and KB Home KBH.
Lyon William sports a Zacks Rank #1 (Strong Buy). Full-year 2017 earnings for Lyon William are expected to increase 38.4%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Lennar, a Zacks Rank #2 (Buy) stock, is expected to witness 7.5% growth in fiscal 2017 earnings.
KB Home, also a Zacks Rank #2 stock, is expected to witness 43.3% growth in fiscal 2017 earnings.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we’re mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold…
By last year, it was already generating $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “”the world’s first trillionaires,”” but that should still leave plenty of money for those who make the right trades early. See Zacks’ Top 3 Stocks to Ride This Space >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Lennar Corporation (LEN): Free Stock Analysis Report
KB Home (KBH): Free Stock Analysis Report
M/I Homes, Inc. (MHO): Free Stock Analysis Report
Lyon William Homes (WLH): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
June 07, 2017 at 05:48PM
from Zacks Equity Research
Medical device major Boston Scientific Corporation BSX recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System. It is a rechargeable, magnetic resonance (MR) conditional device for treatment of movement disorder symptoms in Parkinson’s disease, dystonia and essential tremor patients.
Generally, DBS therapy is a surgical procedure of placing a device that stimulates specific areas in the brain using electrical signals.
The new DBS system consists of Vercise Neural Navigator 2 with STIMVIEW Technology, allowing clinicians to visualize the stimulation field while planning DBS stimulation programs for patients.
Meanwhile, over the last three months, Boston Scientific has been trading above the Zacks categorized Medical – Products industry. As per the latest share price movement, the company has gained 12.2%, compared to 7% gain of the broader industry. We expect the growing adoption of Boston Vercise DBS system in the U.S. and Europe to enhance the company’s Neuromodulation business prospects and boost its share price.
Notably, the latest CE mark expands Boston Scientific’s Vercise Directional portfolio which is composed of the Vercise Primary Cell (PC) and Vercise Gevia platforms with Vercise Cartesia Directional Lead. The Vercise Directional offerings are considered to be the only DBS solutions that help in delivering accurate stimulation therapy to the neural target for avoiding side effects and obtaining optimal outcomes.
Management claimed that Boston Scientific was the first to bring an eight contact rechargeable platform offering 25 years of durability five years ago. This was followed by the launch of the first directional lead powered by a small primary cell device. The latest Vercise Gevia System also has the advantage of an unparalleled 25-year battery life.
As per a Transparency Market Research report, the global DBS market is projected to reach a value of $3.21 billion by 2020 at a CAGR of 8.9%. This growing trend is primarily based on the increasing number of people suffering from neurological diseases across all age population. Neurological movement disorders such as Parkinson’s disease affects nearly 10 million people while Dystonia affects nearly 72 million people globally and is diagnosed more in women.
Zacks Rank & Key Picks
Boston Scientific currently carries a Zacks Rank #3 (Hold). Better-ranked medical stocks include Align Technology, Inc. ALGN, Inogen, Inc. INGN and Accelerate Diagnostics, Inc. AXDX. Notably, Align Technologyand Inogen sport a Zacks Rank #1 (Strong Buy), while Accelerate Diagnostics carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Align Technology has an expected long-term adjusted earnings growth of almost 22.8%. The stock added roughly 44.1% over the last three months.
Inogen has a long-term expected earnings growth rate of 17.5%. The stock has a solid one-year return of around 79.9%.
Accelerate Diagnostics has an expected long-term adjusted earnings growth of 30%. The stock added roughly 13.1% over the last three months.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we’re mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold…
By last year, it was already generating $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “the world’s first trillionaires,” but that should still leave plenty of money for those who make the right trades early. See Zacks’ Top 3 Stocks to Ride This Space >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Inogen, Inc (INGN): Free Stock Analysis Report
Accelerate Diagnostics, Inc. (AXDX): Free Stock Analysis Report
Boston Scientific Corporation (BSX): Free Stock Analysis Report
Align Technology, Inc. (ALGN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
June 07, 2017 at 05:48PM
from Zacks Equity Research
HealthEquity Inc HQY reported earnings of 19 cents per share in the first quarter of fiscal 2018, higher than the Zacks Consensus Estimate of 16 cents. The figure was higher than the year-ago earnings of 14 cents on revenue and margin expansion.
Stock Performance
The price performance of the stock has been favorable over the last three months. HealthEquity rose 11.19%, while the Zacks classified Medical Services sub-industry declined almost 3.01%.
HealthEquity, Inc. Price, Consensus and EPS Surprise
Quarter Details
Revenues came in at $55.4 million, reflecting an increase of 26% year over year and also surpassed the Zacks Consensus Estimate of $55.0 million. Service (41% of total revenues), Custodial (35%) and Interchange (24%) revenues were up 18%, 40% and 21% year over year, respectively.
The growth in service revenues were driven by year-over-year increase in average health savings account (HSA) which was offset by a decrease in service revenue per average HSA. The decline was led by the company’s strategy of offering lower service fees per HSA for more volume from network partners, particularly with higher balances. HealthEquity stated that the profitability of an HSA in this business model increases as balances grow.
The growth in Custodial revenues was supported by higher average daily cash AUM. The strong year-over-year growth in Interchange revenues was driven by increased card spending and more favorable interchange terms (higher spend volume).
As of Apr 30, 2017, total number of HSA members – for which the company serves as a non-bank custodian – increased 26% year over year to 2.8 million. Total assets under management (AUM) surged 28% year over year to $5.2 billion.
Financial Condition
As of Apr 30, 2017, the company had $195.6 million of cash, cash equivalents and marketable securities without any outstanding debt. This compares favorably with $180.4 million in cash, cash equivalents and marketable securities and no outstanding debt as of Jan 31, 2017.
Guidance
For fiscal 2018 (ending Jan 31, 2018), HealthEquity forecasts revenues in the range of $222–$227 million. Net income is forecasted in the range of $33.0 million to $37.0 million, resulting in a net income per diluted share range of 62 cents to 67 cents. Adjusted EBITDA outlook is estimated in the band of $78.0 million to $83.0 million. The business outlook for the fiscal ending Jan 31, 2018 assumes a projected effective income tax rate of approximately 38%.
Zacks Rank and Key Picks
Currently, HealthEquity has a Zacks Rank #3 (Hold).
Few better-ranked medical stocks are Align Technology, Inc. ALGN, Inogen, Inc. INGN and Accelerate Diagnostics, Inc. AXDX. Align Technology and Inogen sport a Zacks Rank #1 (Strong Buy), while Accelerate Diagnostics carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Align Technology has an expected long-term adjusted earnings growth of almost 22.8%. The stock roughly added 45.7% over the last three months.
Inogen has a long-term expected earnings growth rate of 17.5%. The stock has solid one-year return of around 79.7%.
Accelerate Diagnostics has expected long-term adjusted earnings growth of 30%. The stock has added 14% roughly over last three months.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we’re mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold…
By last year, it was already generating $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “”the world’s first trillionaires,”” but that should still leave plenty of money for those who make the right trades early. See Zacks’ Top 3 Stocks to Ride This Space >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Inogen, Inc (INGN): Free Stock Analysis Report
Accelerate Diagnostics, Inc. (AXDX): Free Stock Analysis Report
Align Technology, Inc. (ALGN): Free Stock Analysis Report
HealthEquity, Inc. (HQY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
June 07, 2017 at 05:48PM
from Zacks Equity Research
With the Finance sector turning out to be one of the best performers last earnings season, we thought of bringing up one stock that has plenty of upside potential. Today we have chosen – East West Bancorp, Inc. EWBC – for you to consider.
Headquartered in Pasadena, CA, East West Bancorp offers a profitable investment opportunity, driven by steady earnings growth. The company not only beat estimates in the first quarter, but also has been witnessing upward estimate revisions, reflecting analysts’ optimism about its growth prospects.
Over the last 60 days, the Zacks Consensus Estimate for 2017 and 2018 increased 5.2% and 2.7%, respectively. Further, shares of this Zacks Rank #2 (Buy) stock have rallied 5.9%, so far this year as against 5.5% decline for the Zacks categorized West Banks industry.
East West Bancorp has a number of other factors that make it a solid investment option.
Revenue Strength: East West Bancorp’s revenues witnessed a CAGR of 6% over the last five years (2012–2016). Driven by improving rate environment and rising loan demand, the company’s top line is expected to grow 12.8% in 2017 and 8.6% for 2018.
Earnings Growth: East West Bancorp witnessed earnings growth of 18% in the last three to five years. This earnings momentum is likely to continue in the near term as reflected by the company’s projected earnings per share (EPS) growth rate (F1/F0) of 15.9%, compared with industry average of 11.1%.
Further, the company’s long-term (three to five years) estimated EPS growth rate of 10.5% promises rewards for investors in the long run.
Strong Leverage: East West Bancorp’s debt/equity ratio is 0.14 compared with the industry average of 0.18. The relatively strong financial health of the company will help it perform better than its peers under a dynamic business environment.
Superior Return on Equity (ROE): East West Bancorp has an ROE of 12.49%, better than the industry average of 9.85%. This shows that the company reinvests its cash more efficiently.
Valuation Looks Reasonable: East West Bancorp looks undervalued with respect to its Price-to-Earnings (P/E) and PEG ratios. The company has a P/E ratio of 15.75 compared with the industry average of 17.16. Also, the bank’s PEG ratio of 1.50 is below the industry average of 1.81.
Favorable VGM Score: Currently, East West Bancorp has a VGM Score of ‘B’. Our research shows that stocks with a VGM Score of ‘A’ or ‘B’ when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best upside potential.
Other Stocks Worth a Look
Some other stocks worth considering in the same industry include Bank of Hawaii Corporation BOH, Central Pacific Financial Corp. CPF and Preferred Bank PFBC. All three stocks carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Bank of Hawaii has witnessed an upward earnings estimate revision of nearly 1% for the current year, over the past 60 days. Also, over the last one year, its share price rose 8.8%.
Central Pacific Financial earnings estimates were revised 1.9% upward for the current year, in the past 60 days. Also, its share price increased 23.2% over the last one year.
Preferred Bank recorded an upward earnings estimate revision of around 1% for the current year, in the past 60 days. Also, its share price has seen a surge of 52.7% over the last one year.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we’re mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold.
By last year, it was already generating $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “the world’s first trillionaires,” but that should still leave plenty of money for those who make the right trades early. See Zacks’ Top 3 Stocks to Ride This Space >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CPB Inc. (CPF): Free Stock Analysis Report
Bank of Hawaii Corporation (BOH): Free Stock Analysis Report
Preferred Bank (PFBC): Free Stock Analysis Report
East West Bancorp, Inc. (EWBC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
June 07, 2017 at 05:48PM
from Zacks Equity Research
Brazil Q1 GDP -0.4% On Year Vs. -2.5% In Q4, Consensus -0.1%
The material has been provided by InstaForex Company – www.instaforex.com
June 01, 2017 at 05:49PM
from
Fed’s Powell: Balance Sheet By 2022 May Fall To $2.4 Trillion-$2.9 Trillion
The material has been provided by InstaForex Company – www.instaforex.com
June 01, 2017 at 05:49PM
from
|
|
#cartoonsunday #corpgov @dinamedland @nminow
May 28, 2017 at 05:48PM
https://twitter.com/barsallocarlos/status/868809031388979201
from carlos barsallo
|
|
Charlie Helps FRSA retweeted:
4 Reasons You Might Want to Serve on a Board of Directors ow.ly/yKrzW #corpgov
May 28, 2017 at 05:48PM
https://twitter.com/HelpsCharlie/status/868808769563758592
from Charlie Helps FRSA
|
|
Dr. Gary Sheard retweeted:
Corporate Governance Daily is out! http://ift.tt/2mbWemt Stories via @PhilBuffington @LarimerCounty @MobilSenseT #corpgov #ceo
May 28, 2017 at 05:48PM
https://twitter.com/DrBusinessMan/status/868808269418168324
from Dr. Gary Sheard
